Teva Raises Guidance Amid Generics Growth

Firm Is Actively Examining BD Opportunities; Also Provides Update On Israel Conflict

 
• By David Wallace
  
Teva building
Teva has raised its guidance for 2023 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business